Combined gonadotropin therapy to replace mini-puberty in male infants with congenital hypogonadotropic hypogonadism

被引:2
作者
Rhys-Evans, Sophie [1 ]
Howard, Sasha R. [1 ,2 ]
机构
[1] Queen Mary Univ London, William Harvey Res Inst, Ctr Endocrinol, London EC1M 6BQ, England
[2] Barts Hlth NHS Trust, Dept Paediat Endocrinol, London, England
基金
英国惠康基金;
关键词
congenital hypogonadotropic hypogonadism; fertility; gonadotropin deficiency; gonadotropin treatment; Kallmann syndrome; mini-puberty; CONTINUOUS SUBCUTANEOUS INFUSION; FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; LONG-TERM OBSERVATION; LUTEINIZING-HORMONE; TESTICULAR DESCENT; METABOLIC SYNDROME; MEN; TESTOSTERONE; SPERMATOGENESIS;
D O I
10.1111/nyas.15177
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Infants born with severe central disorders of the hypothalamic-pituitary-gonadal axis leading to gonadotropin deficiency not only lack pubertal development in adolescence, but also lack infantile mini-puberty. This period of mini-puberty, where infants have gonadotropin and sex steroid concentrations up into the adult range, is vital for future reproductive capacity, particularly in boys. At present, there is no consensus on the diagnosis or management of infants with gonadotropin deficiency due to congenital hypogonadotropic hypogonadism or multiple pituitary hormone deficiency. Case series suggest that gonadotropin treatment in male infants with absent mini-puberty is effective in promoting both testicular descent in those with undescended testes and also facilitating increased penile size. Moreover, replacement with follicle-stimulating hormone increases the testicular Sertoli cell population, measurable as an increase in testicular volume and inhibin B, thus hypothetically increasing the capacity for spermatogenesis in adult life for these patients. However, long-term follow-up data is limited for both outcomes pertaining to fertility and nonreproductive sequelae, including neurodevelopment and psychological well-being. The use of international registries for patients with gonadotropin deficiency is a key element in the collection of high-quality, geographically widespread data to inform best-practice management from birth to adulthood. For infant boys with congenital hypogonadotropic hypogonadism, traditional management with testosterone therapy leads to improved penile growth but does not encourage testicular development. In contrast, gonadotropin therapy during mini-puberty promotes both testicular descent into the scrotum and stimulates proliferation of the Sertoli cell pool and endogenous production of testosterone by Leydig cells. Thus, gonadotropin replacement in mini-puberty may improve fertility potential and lead to long-term physical and psychological benefits. image
引用
收藏
页码:32 / 40
页数:9
相关论文
共 61 条
[1]   Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism - a clinical perspective [J].
Al Sayed, Yasmin ;
Howard, Sasha R. R. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 (04) :387-394
[2]   Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis [J].
Alexander, Emma C. ;
Faruqi, Duaa ;
Farquhar, Robert ;
Unadkat, Ayesha ;
Yin, Kyla Ng ;
Hoskyns, Rebecca ;
Varughese, Rachel ;
Howard, Sasha R. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 190 (01) :S1-S11
[3]   Monitoring of the treatment of hypogonadotropic hypogonadism in the infant [J].
Alvarez Casano, Maria ;
Lopez Siguero, Juan Pedro .
ANALES DE PEDIATRIA, 2019, 90 (03) :190-192
[4]   Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects [J].
Antonio, L. ;
Caerels, S. ;
Jardi, F. ;
Delaunay, E. ;
Vanderschueren, D. .
ANDROLOGY, 2019, 7 (03) :302-306
[5]   Gonadotropin administration to mimic mini-puberty in hypogonadotropic males: pump or injections? [J].
Avril, Tristan ;
Hennocq, Quentin ;
Lambert, Anne-Sophie ;
Leger, Juliane ;
Simon, Dominique ;
Martinerie, Laetitia ;
Bouvattier, Claire .
ENDOCRINE CONNECTIONS, 2023, 12 (04)
[6]   Testicular descent: INSL3, testosterone, genes and the intrauterine milieu [J].
Bay, Katrine ;
Main, Katharina M. ;
Toppari, Jorma ;
Skakkebaek, Niels E. .
NATURE REVIEWS UROLOGY, 2011, 8 (04) :187-196
[7]   EXPERT CONSENSUS DOCUMENT European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis, diagnosis and treatment [J].
Boehm, Ulrich ;
Bouloux, Pierre-Marc ;
Dattani, Mehul T. ;
de Roux, Nicolas ;
Dode, Catherine ;
Dunkel, Leo ;
Dwyer, Andrew A. ;
Giacobini, Paolo ;
Hardelin, Jean-Pierre ;
Juul, Anders ;
Maghnie, Mohamad ;
Pitteloud, Nelly ;
Prevot, Vincent ;
Raivio, Taneli ;
Tena-Sempere, Manuel ;
Quinton, Richard ;
Young, Jacques .
NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (09) :547-564
[8]   Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone [J].
Bougneres, P. ;
Francois, M. ;
Pantalone, L. ;
Rodrigue, D. ;
Bouvattier, C. ;
Demesteere, E. ;
Roger, D. ;
Lahlou, N. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06) :2202-2205
[9]  
Bouvattier C, 1999, J PEDIATR ENDOCR MET, V12, P339
[10]  
Brito V. N., 2010, PEDIAT HLTH, V4, P539, DOI [10.2217/PHE.10.50, DOI 10.2217/PHE.10.50]